OnQ Neuro

by CorTechs Labs  · Based in United States → — AI-powered quantitative MRI analysis for brain tumors.
Neurosurgery Oncology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact vendor for pricing
Regulatory Status Disclosed

Overview

OnQ Neuro is a fully automated post-processing medical device software developed by CorTechs Labs. It is designed to assist radiologists, oncologists, and other clinicians in the analysis and interpretation of neurological MR images. The software performs automatic segmentation and volumetric quantification of brain tumors, which are known or confirmed to be pathologically diagnosed cancer. Additionally, OnQ Neuro provides automatic fusion of derived parametric maps with anatomical MRI data and enables the comparison of derived image metrics from multiple time-points. Utilizing deep learning, OnQ Neuro aims to enhance the accuracy and efficiency of brain tumor evaluation. It is intended for use in the adult population only, providing quantitative reports and derived image data sets as complementary information in case review.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Fully automated post-processing medical device software
  • Automatic segmentation and volumetric quantification of brain tumors
  • Analysis and interpretation of neurological MR images
  • Automatic fusion of derived parametric maps with anatomical MRI data
  • Comparison of derived image metrics from multiple time-points
  • Utilizes deep learning for tumor segmentation and quantification
  • Supports DICOM images
  • Generates quantitative reports
  • Intended for adult population only
  • Output of DICOM-compatible objects (RT-Struct)

Use Cases

  • Assisting radiologists, oncologists, and clinicians with neurological MR image analysis
  • Evaluating brain tumors (known/confirmed pathologically diagnosed cancer)
  • Monitoring disease progression through comparison of multiple time-points
  • Discriminating tumor from non-tumor tissue
  • Measuring tumor progression and treatment response
  • Predicting clinical outcomes

What Physicians Need to Know

Brain MRI/CT Analysis
OnQ Neuro is a fully automated post-processing medical device software that assists with the analysis and interpretation of neurological MR images. It performs automatic segmentation and volumetric quantification of brain tumors. The software is intended for use on brain tumors that are known or confirmed to be pathologically diagnosed cancer. It also provides automatic fusion of derived parametric maps with anatomical MRI data and is intended for comparing derived image metrics from multiple time-points. OnQ Neuro's automatic segmentation performance has been evaluated and found to be accurate for clinical practice. Cortechs.ai also offers NeuroQuant CT for automated CT software for fast, accurate diagnosis, including automated CT alignment, lateral ventricle volume quantification, and midline shift calculation.
Seizure Detection
NeuroQuant Seizure is an advanced imaging tool that quantifies hippocampal volume and asymmetry, providing objective, data-driven insights for radiologists and neurologists. It measures the size difference between the left and right hippocampi, which can indicate structural brain changes due to epilepsy. The tool uses advanced image processing algorithms for automated and accurate analysis of MRI scans, aiding in diagnosis, treatment options, and surgical considerations for epilepsy patients. The Hippocampal Asymmetry Report is specifically designed for assessing temporal lobe epilepsy and unilateral degenerative conditions.
Neurodegenerative Disease Screening
Cortechs.ai's cloud-based AI software is designed to segment, quantify, and compare brain structure volume for neurodegenerative diseases. NeuroQuant offers various reports for assessing neurodegenerative conditions, including Age-Related Atrophy (Dementia Report), Microvascular Ischemic Disease (Microvascular Report), Triage Brain Atrophy (TBA Report), Multi-Structure Atrophy (MSA Report), and a customizable volumetric report. These reports quantify neurodegeneration in specific brain regions, provide normative percentile comparisons, and can track progression over time. NeuroQuant also supports the assessment of conditions like Alzheimer's disease, multiple sclerosis, traumatic brain injury, and epilepsy.
Physician Tip

OnQ Neuro is a post-processing tool that assists in the analysis of neurological MRI images, particularly for brain tumors. Physicians retain ultimate responsibility for diagnosis and treatment decisions. The software provides automated segmentation, quantification, and reporting of image metrics, and can fuse parametric maps with anatomical MRI data. For neurodegenerative diseases, NeuroQuant offers various reports that quantify brain structure volumes, compare them to normative data, and can track changes longitudinally. The NeuroQuant Seizure report specifically aids in assessing hippocampal asymmetry for temporal lobe epilepsy. When using NeuroQuant for longitudinal analysis, ensure consistency in MRI manufacturer, field strength, and protocol across studies. The 'research mode' in NeuroQuant can be used for non-clinical processing with relaxed atlas alignment checks, but segmentations should be carefully reviewed by a radiologist for accuracy.

OnQ Neuro is a stand-alone medical device software package that can be installed in the cloud or within a hospital's IT infrastructure on a server or PC-based workstation. It automatically processes images sent from the originating system (MRI scanner or PACS) and outputs DICOM files as image series and reports that can be displayed on most third-party commercial DICOM workstations. Cortechs.ai solutions, including NeuroQuant and OnQ Prostate, are being integrated into Microsoft's PowerScribe One and broader Microsoft ecosystem for seamless workflow integration and enhanced diagnostic confidence. Cortechs.ai's portfolio is also available through the deepcOS® platform, a vendor-neutral AI platform, and CARPL.ai's radiology AI marketplace, expanding access to these solutions within clinical workflows. Additionally, Cortechs.ai has partnered with Viz.ai to integrate NeuroQuant and NeuroQuant MS into the Viz.ai platform, aiming to expand access to quantitative neuroimaging for neurodegenerative diseases.

Details

Category Neurology AI, Oncology AI
Pricing Contact vendor for pricing
DeploymentCloud-based
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated
Integrations
EHR Not specified
Specialties Neurosurgery, Oncology, Radiology

What the Web Says

OnQ Neuro by Cortechs.ai is an FDA-cleared, fully automated post-processing medical device software designed for analyzing and evaluating neurological MRI data, specifically for brain tumors. It provides automatic segmentation, quantification, and reporting of derived image metrics, aiming to enhance efficiency, accuracy, and clinical relevance in neuroimaging. The software integrates into existing radiology workflows and provides objective data to support clinical decision-making.

Overall: Positive

Strengths

  • Fully automated segmentation and quantification of brain tumors on MRI.
  • Provides objective and consistent analysis of brain tumors, reducing variability in interpretations.
  • Offers longitudinal tracking of tumor changes, aiding in monitoring treatment response and disease progression.
  • Integrates into Picture Archiving and Communication Systems (PACS) and can be deployed in the cloud or on-premise.
  • Aids in the assessment of various brain tumor types, including gliomas, metastases, and meningiomas.
  • Designed to save clinicians time and improve diagnostic confidence.

Limitations

  • Limited publicly available independent reviews from physicians, healthcare IT, or tech reviewers outside of company-published materials and scientific papers.
  • No specific reviews found on platforms like Reddit, G2, or Capterra for OnQ Neuro.
  • The software is intended for use by trained personnel only and is to be installed by trained technical personnel.
  • Quantitative reports and derived image data sets are intended to be used as complementary information, with the physician retaining ultimate responsibility for diagnosis and treatment.

Based on reviews from: cortechs.ai, researchgate.net, appliedradiology.com, fda.gov, advancedimg.com

Last updated: 2026-10-29

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate OnQ Neuro

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

newswire.com
Cortechs.ai Awarded Million Dollar NIH Grant for Early Diagnosis of Alzheimer's Disease Using Advanced Diffusion MRI Technique
Cortechs.ai announced it was awarded a million-dollar NIH grant for the early diagnosis of Alzheimer's disease. The company also mentioned the upcoming commercial launch of OnQ Neuro, an FDA-cleared neuro-oncology software, in late 2022.
2022-06
cortechs.ai
Cortechs.ai to Introduce OnQ Neuro at RSNA 2021
Cortechs.ai announced that OnQ Neuro, a recently FDA-cleared device for automated brain tumor segmentation with RSI technology, would be introduced at RSNA 2021.
2021-11
physicianaitools.com
OnQ Neuro by CorTechs Labs is an FDA-cleared, AI-powered software for automated segmentation and volumetric quantification of brain tumors on MRI
OnQ Neuro by CorTechs Labs is an FDA-cleared, AI-powered software for automated segmentation and volumetric quantification of brain tumors on MRI, supporting clinical analysis and interpretation.
2026-10
cortechs.ai
NeuroQuant 4.0: Combining Machine Learning and Deep Learning for Enhanced Brain Structure Segmentation
Cortechs.ai highlights that the power of deep learning, as seen in NeuroQuant 4.0, is also present in their FDA-cleared product, OnQ Neuro, which segments brain tumors by subregion.
2023-02
fda.gov
FDA 510(k) Premarket Notification for OnQ Neuro
The FDA issued a 510(k) premarket notification for OnQ Neuro, indicating its substantial equivalence to the Philips Medical Systems Multi-Modality Tumor Tracking (MMTT, K162955).
2021-11
orthogonal.io
OnQ Neuro FDA Clearance
Cortechs Labs, Inc. received FDA clearance for OnQ Neuro on November 19, 2021.
2021-11
nih.gov
Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor at Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma
This research article discusses the use of Deep Learning software, specifically OnQ Neuro by Cortechs.ai, for segmenting enhancing cellular tumors in glioblastoma.
2025-10
oup.com
Comparing the performance of dynamic susceptibility contrast and arterial spin labeling for detecting residual and recurrent glioblastoma with deep learning and multishell diffusion MRI
A study comparing dynamic susceptibility contrast and arterial spin labeling for detecting glioblastoma utilized Deep Learning software (OnQ Neuro, Cortechs.ai) for segmenting enhancing cellular tumors.
2025-10

Videos

Product demos, reviews, and walkthroughs for OnQ Neuro.

View all on YouTube

Frequently Asked Questions

OnQ Neuro is a fully automated post-processing medical device software from Cortechs.ai designed for analyzing and evaluating neurological MR image data. It provides automatic segmentation, quantification, and reporting of derived image metrics, and can fuse parametric maps with anatomical MRI data. Physicians use it to assist with the analysis and interpretation of neurological MR images, particularly for brain tumors that are pathologically diagnosed cancer, and for comparing derived image metrics from multiple time points.
OnQ Neuro is a medical device software that has received FDA 510(k) clearance (K210831). As such, it must comply with FDA regulations for medical devices, including requirements for registration and listing, labeling, and medical device reporting. The software is intended to be used by trained personnel and installed by trained technical personnel.
Yes, there are several other FDA-cleared AI-powered neuroimaging analysis tools available. Some alternatives include NeuroQuant (also from Cortechs.ai), icometrix icobrain (now GE HealthCare), Quantib ND, Combinostics cNeuro, Neurophet AQUA, and Neuroreader. These tools offer various functionalities for brain MRI volumetrics, MS lesion analysis, dementia assessment, and brain tumor follow-up.
OnQ Neuro is intended for use on brain tumors that are known/confirmed to be pathologically diagnosed cancer. It is designed for the adult population only. While it provides quantitative reports and derived image data, these are intended to be used as complementary information in the review of a case, and the physician retains ultimate responsibility for diagnosis and treatment decisions.
OnQ Neuro is designed as a stand-alone medical device software package that can be installed in the cloud or within a hospital's IT infrastructure on a server or PC-based workstation. Once configured, it automatically processes DICOM images sent from an MRI scanner or PACS and outputs results in standard DICOM format, which can be displayed on most third-party commercial DICOM workstations.

Compare OnQ Neuro

VS
NeuroQuant vs OnQ Neuro
Neurology AI Adjacent · 75/100
NeuroQuant offers broad brain MRI volumetric analysis for neurodegenerative diseases, trauma, and general lesions, including comparisons to normative data. OnQ Neuro, while also from CorTechs Labs, specializes in…

Related Tools

Parkiwatch
Koios Care
Neurology AI
Parkiwatch by Koios Care is a Class IIa Software as a Medical Device (EU MDR 2017/745) for continuous, passive detection and quantitative assessment of kinematic patterns representative of tremor, bradykinesia, and dyskinesia in adults with Parkinson's Disease.
Paid
CortiCare (Virtual EEG Department)
CortiCare
Neurology AI
CortiCare offers 24/7 remote EEG monitoring and interpretation services, functioning as a virtual EEG department to assist hospitals and neurology practices in identifying seizures and other neurological conditions.
NeuroAstra
Avinya NeuroTech
Clinical Decision Support & Reference
NeuroAstra is an AI-enabled EEG analysis and reporting software that provides a multimodal clinical EEG web platform with Co-Pilot AI to help neuro care teams detect abnormal trends faster and standardize reporting.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Paid

See all Neurology AI tools →

More from CorTechs Labs

LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.